iCellate Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 19

Employees

  • Latest Deal Type
  • Liquidation

iCellate General Information

Description

Provider of diagnostic services intended for early cancer detection and profiling. The company's services include liquid biopsy to detect, isolate, and analyze circulating tumor cells (CTCs), germline DNA, and circulating tumor DNA from normal blood samples, enabling healthcare practitioners to initiate treatment sooner and potentially improving patient outcomes.

Contact Information

Website
www.icellate.com
Formerly Known As
Liquid Biopsy
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • Industrivägen 1 3tr
  • 171 48 Solna
  • Sweden
+46 08-400
Primary Industry
Laboratory Services (Healthcare)
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Industrivägen 1 3tr
  • 171 48 Solna
  • Sweden
+46 08-400

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

iCellate Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Bankruptcy: Liquidation 25-Jun-2024 Completed Bankruptcy: Liquidation
12. Later Stage VC Cancelled Generating Revenue
11. Later Stage VC 08-Jun-2023 Completed Generating Revenue
10. Later Stage VC 18-May-2022 Completed Generating Revenue
9. Angel (individual) 04-Dec-2019 Completed Generating Revenue
8. Later Stage VC 31-Dec-2018 Completed Generating Revenue
7. Grant Completed Generating Revenue
6. Accelerator/Incubator Completed Generating Revenue
5. Later Stage VC 30-Jun-2016 $1.93M $2.16M Completed Generating Revenue
4. Early Stage VC 31-Dec-2015 $233K $233K Completed Generating Revenue
To view iCellate’s complete valuation and funding history, request access »

iCellate Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Preference
Preference
Preference 6,667 $31.04 $31.04 1x $31.04 5.05%
To view iCellate’s complete cap table history, request access »

iCellate Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of diagnostic services intended for early cancer detection and profiling. The company's services include liquid
Laboratory Services (Healthcare)
Solna, Sweden
19 As of 2024

New York, NY
 

Huntingdon Valley, PA
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

iCellate Competitors (5)

One of iCellate’s 5 competitors is Rarecells, a Venture Capital-Backed company based in New York, NY.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Rarecells Venture Capital-Backed New York, NY
CellSearch Corporate Backed or Acquired Huntingdon Valley, PA
Epic Sciences Venture Capital-Backed San Diego, CA
Foundation Medicine Formerly VC-backed Boston, MA
CelLBxHealth Corporation Guildford, United Kingdom
You’re viewing 5 of 5 competitors. Get the full list »

iCellate Patents

  • 4

    Total Documents Applications and Grants

  • Total Patents Families

  • 3

    Granted

  • Pending

  • Expiring in next 12 mo

iCellate Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-2516619-A1 Device and method for biological sample purification and enrichment Active 22-Dec-2009
EP-2516619-A4 Device and method for biological sample purification and enrichment Active 22-Dec-2009
EP-2516619-B1 Device and method for biological sample purification and enrichment Active 22-Dec-2009
US-20120270312-A1 Device and method for biological sample purification and enrichment Inactive 22-Dec-2009 B01D35/20

iCellate Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

iCellate FAQs

  • When was iCellate founded?

    iCellate was founded in 2011.

  • Where is iCellate headquartered?

    iCellate is headquartered in Solna, Sweden.

  • What is the size of iCellate?

    iCellate has 19 total employees.

  • What industry is iCellate in?

    iCellate’s primary industry is Laboratory Services (Healthcare).

  • Is iCellate a private or public company?

    iCellate is a Private company.

  • What is iCellate’s current revenue?

    The current revenue for iCellate is .

  • How much funding has iCellate raised over time?

    iCellate has raised $10.2M.

  • Who are iCellate’s competitors?

    Rarecells, CellSearch, Epic Sciences, Foundation Medicine, and CelLBxHealth are competitors of iCellate.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process